8 years ago
1
Martin Shkreli is now the CEO of a publicly traded pharmaceutical company
Martin Shkreli is now the CEO of a publicly traded pharmaceutical company. In a release on Thursday, KaloBios named Shkreli CEO and chairman of the board while also adding three new board members. KaloBios saw its stock price rise more than 400% on Thursday after Shkreli and his associates reported that they'd purchased 70% of the company's outstanding shares earlier this week.
Continue Reading
http://finance.yahoo.com
Join the Discussion
Not sure that Martin Shkreli buying an existing pharmaceutical company belongs in /t/entrepreneurship, so much as /t/pricegouging.